Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 52.51

+2.7%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (6868)	8/8/2002 10:05:22 AM
From: aknahow	Read Replies (1) of 52153

Easy to agree that such actions by "analyst" are despicable. but, real doctors, and real subjects, company insiders and people working on trials are potentially picking up information without having to deceive anyone. Would it have been o.k. if the trial was being discussed with a real doctor who had a patient with a real problem? Should not a real doctor with a real potential patient just be referred to a trial center? An if someone claims they are have the condition for which the trial is being run one would hope that a trial being decently run would quickly detect this. The person and the firm involved could be sued, for civil damages. My point is that we are all indignant about a deceptive attempt to obtain inside information but far more information is being obtained by special groups all the time and not much is said. The whole issue of release of conference abstracts illustrates this. Is it any wonder that analyst try to level the playing field?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next